The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 340:157 January 14, 1999 Number 2
NextNext

Blood Stem Cell Transplantation
Autologous Stem Cell Transplantation: Biological and clinical results in malignancies

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Josy Reiffers, John M. Goldman, and James O. Armitage. 276 pp. St. Louis, Mosby, 1998. $120. ISBN 1-85317-291-X.
(Advances in Blood Disorders. Vol. 2.) Edited by Angelo M. Carella. 453 pp. Amsterdam, Harwood Academic, 1997. $120. ISBN 0-3-7186-5933-6.

In 1957, E. Donnall Thomas, who later won the Nobel prize, reported on the first attempts to use hematopoietic stem cells as rescue therapy for patients with leukemia who had received high-dose myelotoxic treatment. The source was bone marrow. Although Goodman and colleagues demonstrated in 1962 that pooled blood from donor mice successfully restored hematopoiesis in inbred mice that had received supralethal doses of radiation, there was not much thought among clinicians at that time of using peripheral blood in clinical transplantation. The assumption was that there were too few stem cells in peripheral blood to ensure successful engraftment. No . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.